NetApp and Google Cloud Introduce Managed Storage Service to Revolutionize Enterprise Workloads in the Cloud
NetApp® (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced an extension of its partnership with Google Cloud to deliver new levels of storage performance combined with the simplicity and the flexibility of the cloud. With the introduction of Google Cloud NetApp Volumes - now available as a fully-managed, first-party service on Google Cloud - customers can seamlessly bring business-critical workloads across both Windows and Linux environments to Google Cloud, even for the most demanding use cases like VMware and SAP migrations—all without refactoring code or redesigning processes.
"NetApp's innovative offering with Google Cloud sets the standard for enterprise-class features in public cloud file storage, establishing a benchmark for the industry,” said Dave McCarthy, Research Vice President, Cloud and Edge Infrastructure Services at IDC. “The recognition of NetApp's name alongside the cloud provider in this first party service underscores its commitment to driving cutting-edge cloud storage solutions that address customer and market challenges."
Google Cloud NetApp Volumes is based on NetApp ONTAP™ data management software and cloud services. Available today, the partnership enables customers to seamlessly extend their workloads into Google Cloud through an automated storage service that’s fully integrated into its service ecosystem, providing enterprise-grade storage, data protection, and business continuity across workloads.
“By extending our collaboration with Google Cloud, NetApp is putting ONTAP storage and data management capabilities into the hands of Google Cloud customers as a first-party service, making it simple to use enterprise-grade storage in their critical workloads, optimize file storage and support Windows, Linux, SAP and VMware workloads,” said Ronen Schwartz, Senior Vice President and General Manager, Cloud Storage at NetApp. “We see our mission as creating cloud storage and data services that are as forward-thinking and easy to use as possible, and this partnership allows us to continue making this vision a reality.”
“Today’s announcement extends our ability to deliver first-party storage and enterprise data management services so organizations can rapidly deploy, run, protect, and scale enterprise workloads with the familiar tools and interface of Google Cloud,” said Sameet Agarwal, Vice President and General Manager, Google Cloud Storage. “We’re thrilled to enhance our File Solutions portfolio by continuing our partnership with NetApp, bringing the flexibility of the cloud to our customers alongside data protection and efficiency.”
Key capabilities of Google Cloud NetApp Volumes include:
- Enterprise-grade, multiprotocol file shares with rich SMB and NFS protocol support for the most demanding Windows or Linux workloads, including Google Cloud’s only storage service to support protocols such as SMB and NFSv4.1(and v3)
- Support for instant capacity additions or changes between performance tiers – without downtime – resulting in the ability to balance investment/performance in real-time
- Built-in data protection that creates efficient, block-level incremental backups that don’t impact uptime or performance while meeting RTO/RPO parameters to ensure optimum application availability
“As an existing NetApp customer leveraging Cloud Volumes ONTAP and Cloud Volumes Service on Google Cloud, we are thrilled to embrace the new Google Cloud NetApp Volumes,” said Anthony Lloyd, Vice President, Technology Services at OpenText. “This fully managed file storage service will provide seamless migration of enterprise applications, like Kubernetes, to Google Cloud without refactoring code or redesigning processes. Ultimately, it will simplify operations across all our IT environments.”
Learn more about Google Cloud NetApp Volumes at https://www.netapp.com/google-cloud/netapp-volumes/.
Additional Resources
Announcing a Game-Changing Advance in High-Performance File Storage for Enterprises
Google Cloud NetApp Volumes Solutions Brief
Introducing Google Cloud NetApp Volumes: Fully Managed File Storage for Enterprise Workloads
About NetApp
NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services, and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230824135812/en/
Contact information
Media Contact:
Kenya Hayes
NetApp
kenya.hayes@netapp.com
Investor Contact:
Kris Newton
NetApp
kris.newton@netapp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 16:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B cell-mediated diseases. Pove is the only BAFF+APRIL inhibitor in pivotal trials for multiple kidney diseases. Next Steps for Pove Development In IgAN Following the announcement that the Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to pove for the treatment of IgAN, FDA recently granted a rolling review of the Biologics License Application (BLA) for pove for this indication. Vertex expects to submit the first module to FDA for potential accelerated approval before t
Qualcomm Announces Quarterly Cash Dividend17.10.2025 16:00:00 EEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom